|Articles|July 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-07-01-2001
  • Volume 0
  • Issue 0

Overruled: No More Dual Pricing

Author(s)Kevin Gopal

European Union-The European Commission’s ban on GlaxoSmith–Kline’s dual pricing policy in Spain halts one of Big Pharma’s attempts to prevent parallel imports in Europe.

Articles in this issue

almost 25 years ago

Pharmacies: OTC Price Wars

almost 25 years ago

One Disease at a Time

almost 25 years ago

Overview of the Industry: A World of Opportunities

almost 25 years ago

The Power Shift

almost 25 years ago

A Giant Stumbles

almost 25 years ago

Submerged

almost 25 years ago

Generic Threat

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content